J&J Medical Connect
TREMFYA®

(guselkumab)

J&J Medical Connect

Connect with us

  • Products

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

TREMFYA® (guselkumab)
Medical Information

TREMFYA – Use in Combination with TNF Inhibitors for the Treatment of Psoriatic Arthritis in Adult Patients – Real-World Evidence

Last Updated: 03/26/2026

SUMMARY  

  • The company cannot recommend any practices, procedures or usage that deviate from the approved labeling.
  • There are no relevant data available from real-world evidence regarding the use of TREMFYA in combination with tumor necrosis factor (TNF) inhibitors for the treatment of psoriatic arthritis in adult patients.

Literature Search

A literature search of MEDLINE®, EMBASE®, BIOSIS Previews®, DERWENT® (and/or other resources, including internal/external databases) conducted on 04 February 2026 did not identify any relevant citations pertaining to this topic.

Would you like to clear and leave your conversation? Message history will be lost.